Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

HPRA, JAZMP inspect Divi’s Laboratories’ Unit-2 Vishakhapatnam

31 Aug 2019

Divi’s Laboratories’ Unit-2 Vishakhapatnam has been inspected by 5 inspectors from HPRA (Ireland) and JAZMP (Slovenia) from August 26, 2019 to August 30, 2019. The inspection at site was focused on general GMP. The inspection has concluded successfully with no critical observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Related Divi's Laboratories Ltd. Links:

Divi's Lab Share Price

4920.80 96.85 (2.01%) Jul 26, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 703.55
Dr. Reddy's Lab 5409.15
Lupin 1171.65
Cadila Healthcare 607.10
Aurobindo Pharma 952.95
View more..
Sensex vs Divi's Lab
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback